Saisei Ventures is a leading venture capital firm dedicated to advancing Japan's biotechnology sector by connecting innovative research with global expertise. The firm focuses on building transformative biotech companies that leverage engineered biology to address life-threatening and debilitating diseases. By combining Western business acumen with Japanese scientific innovation, Saisei Ventures aims to create globally competitive companies that significantly impact patient lives.

Their investment strategy emphasizes emerging therapeutic platforms, scalable manufacturing processes, and a clear path from proof of concept to investigational new drug (IND) applications.